Details of the Drug

General Information of Drug (ID: DMDO6JP)

Drug Name

HMaxi-K

Indication

Disease Entry	ICD 11	Status	REF
Overactive bladder	GC50.0	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01870037) Phase 1 Study in Subjects With OAB Assessing the Safety and Activity of 2 Doses of hMaxi-K Gene Transfer Injected Directly Into the Bladder Wall. U.S. National Institutes of Health.